General Information of the Compound
Compound ID
CP0476619
Compound Name
N-[4-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)butyl]quinoline-3-sulfonamide
    Show/Hide
Structure
Formula
C20H23N3O2S2
Molecular Weight
401.557
Canonical SMILES
O=S(=O)(NCCCCN1CCc2sccc2C1)c1cnc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C20H23N3O2S2/c24-27(25,18-13-16-5-1-2-6-19(16)21-14-18)22-9-3-4-10-23-11-7-20-17(15-23)8-12-26-20/h1-2,5-6,8,12-14,22H,3-4,7,9-11,15H2
    Show/Hide
InChIKey
KNXYPLSGYHZXCL-UHFFFAOYSA-N
Physicochemical Property
logP
3.4131
Rotatable Bonds
7
Heavy Atom Count
27
Polar Areas
62.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 57400828
ChEMBL ID
CHEMBL1917349
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1082 nM
   TI
   LI
   LO
   TS